wherein Z,A,B,R,R1,R2,Q and n are described herein.It is an object of certain embodiments of the present invention to provide new compounds which exhibit affinity for the ORL1 receptor and one or more of the μ,δ or κ receptors for treating a patient suffering from chronic or acute pain."/>
公开/公告号EP1918279A2
专利类型
公开/公告日2008-05-07
原文格式PDF
申请/专利权人 EURO-CELTIQUE S.A.;
申请/专利号EP20080150838
申请日2002-04-18
分类号C07D211/04;C07D211/06;C07D235/24;C07D413/04;C07D235/26;C07D401/04;C07D401/06;C07D403/04;C07D403/06;A61K31/44;A61K31/48;A61K31/415;A61K31/445;A61P25/04;
国家 EP
入库时间 2022-08-21 19:56:04